Media

Schneider Wallace Appointed Lead Counsel In Case Alleging Dangerous HIV Medication Against Gilead Sciences

On October 11, 2019 The Honorable Andrew Cheng of the Superior Court for the County of San Francisco appointed Schneider Wallace Attorney Amy Eskin to be Co-Lead Counsel in the California Coordinated Proceeding of Gilead Tenofovir Cases (JCCP No 5043)   The Coordinated Proceeding involves cases filed by more than 1,200 individuals who have been injured as a result of taking certain prescription medications developed to treat individuals infected with HIV or those at risk for contracting HIV. These drugs all contain TDF (tenofovir disoproxil fumarate).These drugs include:

  • TRUVADA®
  • VIREAD®
  • ATRIPLA®
  • STRIBILD®
  • COMPLERA®

What is a Coordinated Proceeding?

In California, “complex” actions, such as the those against Gilead Sciences, Inc. regarding TDF-containing medications, where multiple cases are filed in more than one county involving a common question of fact or law, the Court may order that the cases be brought together in a single court under certain procedures and with the agreement of the parties,  This is known as a Judicial Council Coordinated Proceeding (“JCCP”)  It is not a class action.  The goal of coordinating similar cases is to allow for quicker and more efficient proceedings.   Judge Cheng is the Judge assigned to manage the cases

Schneider Wallace Cottrell, Konecky Wotkyns LLP represents many people injured as a result of taking TDF drugs and is actively prosecuting these cases against Gilead Sciences, Inc.